• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter Telegram
Asian Pacific Journal of Cancer Prevention
Articles in Press
Current Issue
Journal Archive
Volume Volume 19 (2018)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 18 (2017)
Volume Volume 17 (2016)
Volume Volume 16 (2015)
Volume Volume 15 (2014)
Volume Volume 14 (2013)
Volume Volume 13 (2012)
Volume Volume 12 (2011)
Volume Volume 11 (2010)
Volume Volume 10 (2009)
Volume Volume 9 (2008)
Volume Volume 8 (2007)
Volume Volume 7 (2006)
Volume Volume 6 (2005)
Volume Volume 5 (2004)
Volume Volume 4 (2003)
Volume Volume 3 (2002)
Volume Volume 2 (2001)
Volume Volume 1 (2000)
Jalili, M., Yaghmaie, M., Ahmadvand, M., Alimoghadam, K., Mousavi, S., Vaezi, M., Ghavamzadeh, A. (2018). Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis. Asian Pacific Journal of Cancer Prevention, 19(2), 325-329. doi: 10.22034/APJCP.2018.19.2.325
Mahdi Jalili; Marjan Yaghmaie; Mohammad Ahmadvand; Kamran Alimoghadam; Seyed Asadollah Mousavi; Mohammad Vaezi; Ardeshir Ghavamzadeh. "Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis". Asian Pacific Journal of Cancer Prevention, 19, 2, 2018, 325-329. doi: 10.22034/APJCP.2018.19.2.325
Jalili, M., Yaghmaie, M., Ahmadvand, M., Alimoghadam, K., Mousavi, S., Vaezi, M., Ghavamzadeh, A. (2018). 'Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis', Asian Pacific Journal of Cancer Prevention, 19(2), pp. 325-329. doi: 10.22034/APJCP.2018.19.2.325
Jalili, M., Yaghmaie, M., Ahmadvand, M., Alimoghadam, K., Mousavi, S., Vaezi, M., Ghavamzadeh, A. Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis. Asian Pacific Journal of Cancer Prevention, 2018; 19(2): 325-329. doi: 10.22034/APJCP.2018.19.2.325

Prognostic Value of RUNX1 Mutations in AML: A Meta-Analysis

Article 5, Volume 19, Issue 2, February 2018, Page 325-329  XML PDF (365 K)
Document Type: Systematic Review and Meta-analysis
DOI: 10.22034/APJCP.2018.19.2.325
Authors
Mahdi Jalili1, 2; Marjan Yaghmaie1; Mohammad Ahmadvand 1; Kamran Alimoghadam1; Seyed Asadollah Mousavi1; Mohammad Vaezi1; Ardeshir Ghavamzadeh1
1Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
2Hematologic Malignancies Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Receive Date: 03 October 2017,  Revise Date: 11 November 2017,  Accept Date: 16 December 2017 
Abstract
 
The RUNX1 (AML1) gene is a relatively infrequent mutational target in cases of acute myeloid leukemia (AML). Previous work indicated that RUNX1 mutations can have pathological and prognostic implications. To evaluate prognostic value, we conducted a meta-analysis of 4 previous published works with data for survival according to RUNX1 mutation status. Pooled hazard ratios for overall survival and disease-free survival were 1.55 (95% confidence interval (CI) = 1.11–2.15; p-value = 0.01) and 1.76 (95% CI = 1.24–2.52; p-value = 0.002), respectively, for cases positive for RUNX1 mutations. This evidence supports clinical implications of RUNX1 mutations in the development and progression of AML cases and points to the possibility of a distinct category within the newer WHO classification. Though it must be kept in mind that the present work was based on data extracted from observational studies, the findings suggest that the RUNX1 status can contribute to risk-stratification and decision-making in management of AML.
Keywords
acute myeloid leukemia; AML1/RUNX1 mutation; prognosis; Meta-analysis
Main Subjects
Hematology
Statistics
Article View: 197
PDF Download: 144
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

 



 

Journal Management System. Designed by sinaweb.